Serum hormone levels in WT, HET and HOM animals. by Wendy J. Bailey (14926392)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on photosynthetic gas exchange parameters of HHZ and XLY900 at days 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Spatial distribution of APCA (Map from the Ministry of Natural Resources of China, cartographic license: GS (2020) 4619). by Wenping Ning (19871091)

Subjects:

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

Subjects:

Quantile regression results. by Pu Miao (12886949)

Subjects:

A set of 5 criteria for the needs of multi-criteria evaluation–combination A. by Roman Vavrek (13200141)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Summary of study participants. by Jesús Poch-Páez (21807825)

Subjects:

DSP: Digital Spatial Profiling. by Jinho Lee (587173)

Subjects:

Fundamental Characteristics of Participants by PAL. by Haiwei Li (282229)

Subjects:

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Subjects:

Attitude towards hand eczema among hair dressers of Debre Berhan city, January 10-February 20, 2025. by Belachew Tekleyohannes Wogayehu (19470257)

Subjects:

Identification of the most important and least important criterion using the SD method ‐ all combinations. by Roman Vavrek (13200141)

Subjects:

Exploring the correlation between systemic inflammation biomarkers and HCV infection (logarithm base 2). by Lu Han (151620)

Subjects:

Main components of bauxite and BCFD (wt.%). by Nian Liu (29935)

Subjects:

Combined Morphological and IHC Data: Combined Morphological and Immunohistochemistry Data. by Jinho Lee (587173)

Subjects:

Invention patent applications and grants in China. by Pu Miao (12886949)

Subjects:

Regression results of the different number of patents. by Pu Miao (12886949)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

The importance of entry criteria from the point of view of the SD method ‐ combinations D1 –D10. by Roman Vavrek (13200141)

Subjects: